Summary Walmart has remained more resilient to COVID-19 than non-food retailers, as consumers increasingly prioritize grocery items.
Walmart has been making changes to better support its staff throughout the COVID-19 crisis, which will help to prove its ethical standards, and be remembered by its consumers and stakeholders in the long term.
The coronavirus (COVID-19) company impact report analyses how the pandemic will impact Walmart’s performance.
Scope - The essential nature of Walmart’s business, alongside its superior online proposition, puts it in good stead to maintain appeal amid the pandemic.
- As Walmart’s largest market, the rapid increase in the number of COVID-19 cases in North America will put considerable pressure on its operations, so it must utilise its learnings from its Chinese fascias to adapt its proposition.
Reasons to Buy - Use our revised 2020 forecast for Walmart to understand how it will perform this year.
- Use our charts to review how Walmart’s sales are split by region globally and how these regions have been impacted by COVID-19.
- Use our in-depth analysis to review how Walmart has responded to COVID-19 and how this will affect its performance.
Our reports have been used by over 10K customers, including:
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
Anatomic Pathology Market Report Overview Anatomic Pathology market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Anatomic Pathology market types and applications. It is a focused study on Anatomic Pathology market space including global...
Pathology Devices Market Report Overview Pathology Devices market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pathology Devices market types and applications. It is a focused study on Pathology Devices market space including global and...
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The global human microbiome market is expected to reach US$ 1,873.53 million by 2027 from US$ 356.29 million in 2019. The market is estimated to grow with a CAGR of 23.6% from 2020 to 2027. The growth of the market is driven by the factors such as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies,...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
No air: Demand for industry services has declined as a result of the closure of nonessential businesses Abstract Air Duct Cleaning Services in the US Operators in this industry provide air duct cleaning services to buildings and dwellings. This includes the cleaning of heating and cooling system components. This...
Abstract Technical Support & Help Desk Services Procurement in the US This report is intended to assist buyers of technical support and help desk services. Technical support and help desk service providers field questions and incoming calls from customers in need of assistance with product or service features....
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
The global apheresis equipment market grew at a CAGR of around 12% during 2014-2019. Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced...
Pathology
Chronic Disease
Infectious Disease
Research And Development
Neurological Disorder
Blood Supply
World
Chronic Disease Prevalence
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.